Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03990909 · ClinicalTrials.gov registry record · NA

Pilot Study of BCAA on Sleep

A NA study of Traumatic Brain Injury and Sleep Disorder, sponsored by Portland VA Medical Center.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT03990909: Recruiting NA study of Traumatic Brain Injury and Sleep Disorder, sponsored by Portland VA Medical Center.

NCT03990909 is a NA study of Traumatic Brain Injury and Sleep Disorder that is actively recruiting participants, run by Portland VA Medical Center. The registered enrollment target is 300 participants, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03990909, a NA study of Traumatic Brain Injury and Sleep Disorder, is actively recruiting participants, sponsored by Portland VA Medical Center.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experimental period.

Primary Outcome

Number enrolled per month, proportion who complete the protocol

Interventions

  • DIETARY_SUPPLEMENT Branched Chain Amino Acids
  • DIETARY_SUPPLEMENT Rice Protein
  • DIETARY_SUPPLEMENT Microcrystalline Cellulose

Study Locations (1)

Oregon

  • VA Portland Health Care System - Portland

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2019-03-01
Est. Completion 2025-12-01
Phase NA
Portland VA Medical Center

15 total trials

What NCT03990909 shows while recruiting

NCT03990909 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target.

The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 3 interventions - of which Branched Chain Amino Acids is the first listed.

NCT03990909 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT03990909 about?

NCT03990909 is a clinical study titled "Pilot Study of BCAA on Sleep". Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) a...

What is the current status of trial NCT03990909?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2019-03-01. Estimated completion is 2025-12-01.

What conditions does trial NCT03990909 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Sleep Disorder.

What interventions are being tested in trial NCT03990909?

The interventions under investigation include: Branched Chain Amino Acids (DIETARY_SUPPLEMENT), Rice Protein (DIETARY_SUPPLEMENT), Microcrystalline Cellulose (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03990909?

This trial is sponsored by Portland VA Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03990909 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03990909's enrollment target sits among peer trials

300 20th of 171 higher than 146 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03990909, the US trial registry maintained by the National Library of Medicine. NCT03990909 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.